866-997-4948(US-Canada Toll Free)

Cutaneous Squamous cell Carcinoma-Market Insights, Epidemiology and Market Forecast-2023

Published By :

DelveInsight

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 66 Pages

DelveInsights Cutaneous Squamous Cell Carcinoma (cSCC)- Market Insights, Epidemiology and Market Forecast-2023-7MM report provides an overview of the disease and global market size of the Cutaneous Squamous Cell Carcinoma for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes historical and forecasted epidemiological data for the Incident cases of Cutaneous Squamous Cell Carcinoma from 2013-2023.
Cutaneous Squamous Cell Carcinoma is a keratinocytic or non-melanoma skin cancer. cSCC is considered the second most common human malignancy after basal cell carcinoma (BCC).Actinic keratosis is the premalignant precursor for cSCC and early treatment might reduce patient morbidity. Unlike almost all basal-cell carcinomas, cutaneous squamous cell carcinomas are associated with a substantial risk of metastasis. The prognosis is favorable and only 2-5% of SCC metastasize.
According to DelveInsight, the market size for Cutaneous Squamous Cell Carcinoma of 7MM is estimated to be USD XX Million by 2023 at a CAGR of 6.1% for the forecast period i.e., 2013-2023.
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.
Scope
The report will help in developing business strategies by understanding the trends shaping and driving the Cutaneous Squamous Cell Carcinoma market.Organize sales and marketing efforts by identifying the best opportunities for Cutaneous Squamous Cell Carcinoma in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
To understand the future market competition in the 7MM of Cutaneous Squamous Cell Carcinoma and Insightful review of the key market drivers and barriers.
The report provides historical as well as forecasted epidemiology of Cutaneous Squamous Cell Carcinoma in the 7MM.
To understand the regulatory scenario in major markets
The Report also covers the detailed historical and forecasted Cutaneous Squamous Cell Carcinoma market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
Report Introduction 2
Cutaneous Squamous Cell Carcinoma (cSCC) Market Overview at a Glance 8
7 Major Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) (2013-2023) 8
Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2016 9
Total Market Share Distribution of Cutaneous Squamous Cell Carcinoma for 7MM in 2023 9
Introduction 10
Signs and Symptoms 10
Pathophysiology 10
Sub-types of cSCC 12
Risk Factors 13
Staging of cSCC 15
Diagnosis 16
Epidemiology and Patient Population 18
Total number of Incident cases 7MM Countries (2016 & 2023) 19
United States 20
Germany 22
France 23
United Kingdom 25
Spain 27
Italy 28
Japan 30
Treatment Algorithm 32
United States 32
NCCN Guidelines 32
Europe 35
British Association of dermatology (BAD) Guidelines 35
French Dermatology Recommendations Association (aRED) 36
European Dermatology Forum 37
London Cancer Skin Pathway Board 39
National Cancer Institute 40
Unmet Needs 41
Marketed Drugs 42
5-Fluorouracil (5-FU) 42
MOA 42
Study 42
Xeloda 44
MOA 44
Study 44
Cisplatin 45
MOA 45
Study 45
Bleomycin 46
MOA 46
Study 46
Doxorubicin 47
MOA 47
Cetuximab 48
MOA 48
Study 48
Gefitinib 49
MOA 49
Study 49
Cutaneous Squamous Cell Carcinoma (cSCC): Country-Wise Market Analysis 51
Region-Specific Market Distribution and Comparison 51
Overview on Cutaneous Squamous Cell Carcinoma (cSCC) (2016) 52
Overview on Cutaneous Squamous Cell Carcinoma(cSCC) (2023) 53
Global Cutaneous Squamous Cell Carcinoma (cSCC): Market Analysis 54
United States Market Size 55
Europe 56
GermanyMarket Size 56
France Market Size 57
United Kingdom Market Size 58
Spain Market Size 59
Italy Market Size 60
Japan Market Size 61
Market Drivers 62
Market Barriers 62
Appendix 63
Report Methodology 63
Consulting Services 65
Disclaimer 66
About DelveInsight 66

List of Table

Table 1: 7 Major Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD Million (2013-2023) 8
Table 2: Staging of Cutaneous Squamous Cell Carcinoma, 2017 16
Table 3: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC)in United States (2013-2023) 21
Table 4: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC)in Germany (2013-2023) 22
Table 5: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in France (2013-2023) 24
Table 6:Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in United Kingdom (2013-2023) 26
Table 7: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Spain (2013-2023) 27
Table 8: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Italy (2013-2023) 29
Table 9: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Japan (2013-2023) 31
Table 10: Region specific market distribution and comparison 51
Table 11: Cutaneous Squamous Cell Carcinoma (cSCC), Market Revenue (2016) as per the 7MM 52
Table 12: Cutaneous Squamous Cell Carcinoma(cSCC), Market Revenue (2023) as per the 7MM 53
Table 13: United States Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 55
Table 14: Germany Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 56
Table 15: France Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 57
Table 16: United Kingdom Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 58
Table 17: Spain Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 59
Table 18: Italy Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 60
Table 19: Japan Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 61

List of Chart

Figure 1: Pathophysiology of Cutaneous Squamous Cell Carcinoma 11
Figure 2: Risk Factors of Squamous Cell Skin Carcinoma 13
Figure 3: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in United States (2013-2023) 21
Figure 4: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Germany (2013-2023) 22
Figure 5: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in France (2013-2023) 24
Figure 6: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in United Kingdom (2013-2023) 26
Figure 7: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Spain (2013-2023) 27
Figure 8: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Italy (2013-2023) 29
Figure 9: Incident Cases of Cutaneous Squamous Cell Carcinoma (cSCC) in Japan (2013-2023) 31
Figure 10: Clinical Presentation of Squamous Cell Skin Carcinoma 32
Figure 11: Primary and Adjuvant therapy for low risk Squamous Cell Carcinoma 33
Figure 12: Primary and Adjuvant therapy for High risk Squamous Cell Carcinoma 34
Figure 13: Treatment of Primary Cutaneous Squamous Cell Carcinoma 35
Figure 14: Treatment of Primary Cutaneous Squamous Cell Carcinoma 39
Figure 15: Region specific market distribution and comparison 51
Figure 16: Total 7 Major Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2016) 52
Figure 17: Total 7 Major Market Size of Cutaneous Squamous Cell Carcinoma(cSCC) in USD, Million (2023) 53
Figure 18: United States Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 55
Figure 19: Germany Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 56
Figure 20: France Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 57
Figure 21: United Kingdom Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 58
Figure 22: Spain Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 59
Figure 23: Italy Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 60
Figure 24: Japan Market Size of Cutaneous Squamous Cell Carcinoma (cSCC) in USD, Million (2013-2023) 61

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *